RNTX

Rein Therapeutics, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

2

Buys

2

Sells

0

Largest Trade

$100K–$500K

Insiders

1

Institutional Funds

35

Inst. Value

$1M+

Activist Filings

12

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Voss Capital, LP10% OwnerBUY$100K–$500K104K$1.22Nov 18, 2025
Voss Capital, LP10% OwnerBUY$100K–$500K306K$1.38Oct 28, 2025
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 35 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Voss Value Master Fund, LP

SC 13G/A · Feb 13, 2026

3.5%

926K shares

Voss Value Master Fund, LP

SC 13G/A · Sep 26, 2025

3.0%

699K shares

BIOS FUND III, LP

SC 13G · Aug 11, 2025

0.7%

431K shares

Voss Value Master Fund, LP

SC 13G · May 15, 2025

2.5%

583K shares

4.4%

961K shares

Muneer A. Satter

SC 13D/A · Apr 16, 2024

4.9%

830K shares

Muneer A. Satter

SC 13D/A · Mar 5, 2024

5.9%

1.0M shares

Biotechnology Value Fund, L.P.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

BIOS FUND I, LP

SC 13G · Nov 13, 2023

10.0%

539K shares

Muneer A. Satter

SC 13D/A · Nov 3, 2023

19.9%

1.0M shares

Biotechnology Value Fund, L.P.

SC 13G/A · Feb 14, 2023

2.8%

126K shares

View on Google Finance →